1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

        <em id="8sgz1"><label id="8sgz1"></label></em>
      2. <em id="8sgz1"><label id="8sgz1"></label></em>
        <em id="8sgz1"></em>
        <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

        <button id="8sgz1"></button>
        west china medical publishers
        Author
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Author "LIU Zhitao" 2 results
        • Effectiveness of Noninvasive Positive Pressure Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated with Severe Type Ⅱ Respiratory Failure

          Objective To investigate the effectiveness of noninvasive positive pressure ventilation( NPPV) in acute exacerbation of chronic obstructive pulmonary disease ( AECOPD) complicated with severe type Ⅱ respiratory failure.Methods 37 patients who were admitted fromJanuary 2008 to June 2009 due to AECOPD complicated with severe type Ⅱ respiratory failure and had received NPPV therapy were enrolled as a NPPV group. Another similar 42 cases who had not received NPPV therapy served as control. All subjects received standard medication therapy according to the guideline. Arterial blood gases before and after treatment, the duration of hospitalization and intubation rate were observed. Results The arterial pH, PaO2 ,and PaCO2 improved significantly after treatment as compared with baseline in both groups ( P lt; 0. 05) .Compared with the control group, the average duration of hospitalization was significantly shorter ( 10 ±5 vs.19 ±4 days, P lt;0. 05) and the intubation rate was significantly lower ( 2. 7% vs. 16. 7% , P lt;0. 05) in the NPPV group. Conclusion The use of NPPV in AECOPD patients complicated with severe type Ⅱ respiratory failure is effective in improving arterial blood gases, reducing the duration of hospitalization and intubation rate.

          Release date:2016-08-30 11:53 Export PDF Favorites Scan
        • Selective Interventional Therapy for Liver Cancer Related Portal Hypertension

          目的 評價選擇性介入治療在原發性肝癌(HCC)門脈高壓癥中的應用價值。 方法 2008年11月-2011年3月,收治65例臨床明確診斷的HCC伴門脈高壓癥患者,選擇性使用肝動脈化學療法(化療)栓塞術、脾栓塞術、門靜脈化療栓塞術、門靜脈支架、胃冠狀靜脈栓塞術等介入術式,術后通過觀察臨床指標、定期復查影像檢查等了解病變轉歸,隨訪生存期并評價療效。 結果 65例HCC患者均合并不同程度門靜脈高壓,其中門靜脈癌栓46例中有37例顯示肝動脈-門靜脈分流,通過肝動脈及門靜脈化療栓塞術進行主瘤體及癌栓治療。11例行門靜脈支架置入術,支架置入后門靜脈壓較術前明顯下降(P<0.01),支架中位通暢時間為5.8個月。39例行胃冠狀靜脈和(或)胃短靜脈栓塞術,術后有4例再次發生門脈高壓性出血,再出血率10.26%。18例行脾動脈栓塞術,術后3個月血小板較術前顯著升高(P<0.01)。隨訪術后3、6、12及24個月的生存率分別為90.77%、69.23%、35.38%及13.85%。 結論 選擇性聯合使用各種介入術式是治療HCC及其相關性門脈高壓癥的一種有效方法,可有效預防高危風險,延長患者生存期。

          Release date:2021-06-23 07:35 Export PDF Favorites Scan
        1 pages Previous 1 Next

        Format

        Content

          1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

            <em id="8sgz1"><label id="8sgz1"></label></em>
          2. <em id="8sgz1"><label id="8sgz1"></label></em>
            <em id="8sgz1"></em>
            <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

            <button id="8sgz1"></button>
            欧美人与性动交α欧美精品